Private Label Tranexamic Acid Kojic Acid Underarm Cream

Minimum order quantities for private label tranexamic acid and kojic acid underarm cream typically range from 500 units to 5,000 units per SKU, depending on the manufacturer's production capacity, your brand's timeline, and whether you're ordering a stock formula or requesting a custom blend. Most contract manufacturers and co-packers in the cosmetics space have moved toward lower MOQs in recent years to accommodate indie brands and smaller founders, but the floor varies significantly based on several factors. For a completely custom formulation—where the manufacturer must develop and validate a unique blend of tranexamic acid and kojic acid at specific concentrations, stabilize the active ingredients, conduct micro trials, and run stability testing—you'll often see MOQs starting at 2,000 to 5,000 units. This reflects the R&D cost, equipment setup, and quality assurance cycles required. If you're willing to use a pre-existing house formula or a semi-custom variant (where the chemist adjusts preservative, fragrance, or texture but keeps the actives stable), some labs will go as low as 500 to 1,000 units, though this is less common in the underarm category because both tranexamic acid and kojic acid require careful pH buffering and preservation strategies to remain efficacious over shelf life. Regional and regulatory factors also push MOQ floors upward. If your underarm cream must comply with FDA cosmetic regulations (United States), NMPA rules (China), EU Annex III restrictions on certain actives, or TGA guidelines (Australia), the manufacturer may require a higher MOQ to justify the documentation, batch record keeping, and stability data generation that regulators expect. A 1,000-unit run might not warrant the cost of a full 12-month stability study; a 3,000-unit run does. Packaging integration adds another layer. If you're sourcing a custom airless jar, pump bottle, or tube with your logo and a specific closure, the packaging supplier's MOQ (often 5,000 to 10,000 units of a single SKU) may force your finished-goods MOQ upward. Many indie brands solve this by using stock packaging (white airless jars, aluminum tins, or standard pump bottles from shelf inventory) to drop the effective MOQ to 1,000 to 2,000 units while still launching a professional product. The stage of your supply chain also matters. If you're sourcing raw tranexamic acid and kojic acid powder yourself and hiring a formulator to blend them into a cream base, you'll typically need 1,000 to 3,000 units minimum. If you're using a co-packer that holds pre-made bases and actives in bulk, you might negotiate down to 500 to 1,000 units because the co-packer spreads the cost of maintaining those base stocks across multiple clients. A common mistake first-time founders make is assuming that "low MOQ" means 100 or 200 units. In reality, 500 to 1,000 units is genuinely low for a custom active-rich underarm cream; anything below 500 units usually requires paying a significant per-unit premium or working with a very small, boutique formulator who may not have the QA infrastructure you need for retail or online sales. On the AJ Cosmo Labs app and platform, you can filter vetted manufacturers by their stated MOQ minimums and compare whether they offer tiered pricing that rewards larger orders; this transparency helps you benchmark what's truly low for your budget and timeline. If you're launching in a single market first (e.g., the US only), you can often start at 1,000 to 2,000 units. If you're planning international distribution or want to stock multiple retailers, expect to negotiate MOQs of 3,000 to 5,000 units to make the per-unit cost competitive and ensure you don't run out mid-season.

The total cost to manufacture private label tranexamic acid and kojic acid underarm cream breaks down into three main buckets: formulation and R&D, raw materials and actives, and manufacturing and packaging labor. Total landed cost per unit typically ranges from $2 to $8 depending on order volume, active concentrations, packaging quality, and whether you're paying for custom development or using a house formula. For a 1,000-unit run with mid-range packaging, expect $4 to $6 per unit; for a 5,000-unit run with optimized supply, $2 to $4 per unit is achievable. Formulation and R&D costs are front-loaded. If you're requesting a completely custom blend of tranexamic acid (typically 2–5% by weight) and kojic acid (usually 1–3%), plus a stable, lightweight cream base suitable for underarm use, most cosmetic chemists and labs charge $500 to $2,000 for the development phase. This includes literature review, bench-top trials (usually 2–4 iterations), micro-batch stability testing at room temperature and accelerated conditions (40°C/75% humidity for 4 to 8 weeks), and final formula documentation. Some labs roll this cost into the manufacturing price if you commit to a minimum run; others charge it separately. Using a pre-formulated house formula or a semi-custom variant (where you adjust preservative or scent but actives stay the same) cuts R&D to $0 to $500 because the chemist's time is minimal. Raw materials represent 40–60% of your per-unit cost. Tranexamic acid raw powder costs approximately $15 to $30 per kilogram in bulk (5–25 kg quantities). Kojic acid dipalmitate (a stabilized form that doesn't degrade as quickly as kojic acid powder) costs roughly $40 to $80 per kilogram. For a 50 ml or 75 ml underarm cream with tranexamic acid at 3% and kojic acid at 2%, you'll need roughly 0.3 to 0.5 kg of actives per 100 units. Add in emollient oils (jojoba, squalane, silicone), emulsifiers, humectants (glycerin, butylene glycol), preservatives (phenoxyethanol, potassium sorbate, or newer preservative blends), and stabilizers, and raw material cost per unit typically lands at $1 to $3 depending on ingredient tier (commercial-grade vs. cosmetic-grade). Premium or organic-certified versions of any ingredient push this higher. Manufacturing and packaging labor, including mixing, filling, capping, labeling, QA checks, and boxing, costs $0.50 to $2.00 per unit for a small run (1,000–2,000 units) and drops to $0.30 to $0.80 per unit for a larger run (5,000+ units) because the co-packer's fixed overhead is spread across more units. If your packaging is complex (airless pumps, custom jars with embossing), or if you require extra stability documentation or micro-batch water-activity testing, labor costs climb. Packaging itself is a major variable. A simple, pre-printed label on a stock 50 ml white plastic jar with a black flip-top cap costs roughly $0.30 to $0.50 per unit when ordered in volume. A custom-molded airless pump bottle or frosted glass jar with a metallic closure can run $1 to $3 per unit, especially if tooling is required. This is why many indie brands I see on AJ Cosmo Labs start with stock packaging to hit lower per-unit costs, then upgrade packaging after validating market demand. For a realistic 2,000-unit private label run: $800–$1,500 in formulation, $2,000–$4,000 in raw materials, and $1,000–$3,000 in manufacturing and packaging, totaling roughly $3,800–$8,500 in out-of-pocket costs before your margin. That's $1.90 to $4.25 per unit. If you then retail the cream at $28–$48 per jar, your gross margin is healthy even after accounting for wholesale discounts, marketing, and logistics. Common cost pitfalls: underestimating the price of stabilizing tranexamic acid (it hydrolyzes in water, so you need a proper preservative system and lower pH), overestimating what "bulk" actually means (a 5 kg purchase of an active is not bulk in cosmetic manufacturing), and forgetting to budget for compliance documentation if selling in regulated markets. On the AJ Cosmo Labs app, you can request quotes from multiple vetted co-packers and see how their per-unit pricing shifts as MOQ increases; this real-time benchmarking prevents overpaying for small runs.

The total timeline from project kickoff to first shipment of finished goods typically ranges from 12 to 20 weeks for a custom formulation, or 6 to 10 weeks if you're using a house formula or pre-approved active blend. Timeline variability depends on whether you're doing original development, how strict your stability requirements are, packaging lead times, and regulatory approval steps if applicable. Most indie founders underestimate this by 4 to 8 weeks, so clear communication with your co-packer is essential. Week 1–2: Project Brief and Supplier Selection. You define your target product (e.g., a lightweight, fast-absorbing underarm cream with 3% tranexamic acid and 2% kojic acid, pH 4.5–5.5, 50 ml airless jar). You collect competing products for benchmarking, finalize your budget, and choose a chemist or co-packer. Using AJ Cosmo Labs, you can instantly connect with vetted formulators and manufacturers in your region; this cuts the vendor-vetting phase from weeks to days because all suppliers have been admin-reviewed before listing. Week 2–4: Formulation Development and Approval. If you're ordering a custom formula, the lead chemist builds 2–4 bench-scale batches (typically 100–500 ml each), testing different concentrations of tranexamic acid and kojic acid, pH buffers, emulsifier systems, and preservative packages. They run in-house checks for phase separation, odor, viscosity, and basic stability at room temperature. Each iteration cycle takes 3–7 days. If you're using a house formula, this phase collapses to 1–2 weeks because the chemist is only tweaking existing composition, not validating new actives. Some manufacturers skip formal written approval here and move directly to micro-batch production, which risks delays if you reject the sample; insist on documented approval of the formula before proceeding. Week 4–8: Micro-Batch Production and Stability Testing. Once the formula is locked, the co-packer produces a 2–5 kg pilot batch in their GMP facility, filling it into your chosen packaging. This reveals real-world manufacturing issues: Does the cream flow through the pump at the viscosity you specified? Does the jar close properly? Are there any separation or settling issues after 24 or 48 hours? In parallel, stability samples are placed in a climatic chamber at 40°C and 75% relative humidity (accelerated conditions) and at room temperature for baseline comparison. Regulations typically require 4 to 8 weeks of accelerated stability data for cosmetics, though some markets (and some retailers) accept 4-week data if chemistry supports it. If your formula includes novel combinations of actives (tranexamic acid + kojic acid together are less common than either alone), expect some back-and-forth with the chemist to ensure the actives don't degrade or interact. Week 8–10: Regulatory and Compliance Review. If you're selling in the US, your formula and ingredient list are evaluated against FDA cosmetic regulations; if not selling as a "cosmetic" (topical skincare) but as a "drug" (acne or dermatitis claim), timelines extend by weeks or months pending clinical validation. EU brands must check Annex III for any restricted actives; most tranexamic acid and kojic acid formulations are compliant, but if you're also including hydroquinone or other depigmenting agents, this phase flags it early. China, Australia, Japan, and other markets have their own pre-market review steps. This is where many indie founders hit delays; do not skip this even if launching to a "small" market first. Week 10–14: Packaging and Label Finalization. Your label design is submitted to compliance (ingredient disclosure, warnings, directions, company contact info). Stock packaging (pre-made jars and caps) usually ships in 2–3 weeks from order. Custom packaging (embossed jars, printed caps) can take 6–10 weeks, which is often the longest single lead time in the project. Order packaging early; if it's delayed, the entire project stalls. Some founders order stock packaging for the first run and upgrade to custom after validating sales, which shaves 4–6 weeks off the initial launch timeline. Week 14–18: Full-Scale Manufacturing Run. Once stability passes, raw materials are sourced at full MOQ, the formula is scaled up in the co-packer's mixing tanks, batch records and certificates of analysis are generated, and the full run (e.g., 2,000 units) is produced, filled, capped, labeled, and quality-checked. This phase typically takes 2–4 weeks depending on queue and equipment availability. If the co-packer is busy or you've ordered during peak season (Q4 for holiday launches), add 1–2 weeks. Week 18–20: Final QA, Batch Testing, and Shipping. The finished product undergoes final microbial testing (to ensure preservative efficacy), pH verification, viscosity spot-checks, and labeled unit inspection. Depending on your market, you may require microbiological testing by a third-party lab (1–2 weeks) or accept the co-packer's in-house QA (3–5 days). Once cleared, goods are boxed and shipped. If you're importing internationally, customs clearance can add 1–2 weeks. Common timeline killers: (1) Underestimating packaging lead times—order packaging by Week 5 or 6, not Week 12. (2) Requesting changes to the approved formula after pilot production—each change cycle adds 2–4 weeks. (3) Skipping the micro-batch step and going straight to full scale—if something goes wrong at scale, you've lost 1–2 weeks and thousands of dollars. (4) Not confirming regulatory compliance before development starts—discovering a formula is non-compliant mid-manufacturing delays launch by 4–8 weeks. On the AJ Cosmo Labs platform, you can coordinate timelines directly with your chosen manufacturer and receive milestone notifications, helping you stay on track and catch delays early.

Tranexamic acid (also called trans-4-aminomethyl cyclohexanecarboxylic acid) is typically used at 2–5% w/w concentration in underarm creams targeting hyperpigmentation, post-inflammatory hyperpigmentation (PIH), or general brightening. Kojic acid or its stabilized derivative, kojic acid dipalmitate, is usually formulated at 1–3% w/w. These ranges are based on efficacy studies, safety data, and what's commonly found in retail products; however, efficacy varies with pH, emulsion stability, and whether the formula includes synergistic actives like niacinamide or licorice extract. There is no universal regulatory cap on either ingredient for cosmetics in most major markets (US, EU, China), but formulation strategy and stability validation determine what concentration is legally defensible and commercially viable. Transexamic acid in topical applications has been studied extensively for melasma, post-inflammatory hyperpigmentation, and general skin brightening, with effective concentrations ranging from 2–10% in clinical trials. However, most commercial underarm creams use 2–5% because higher concentrations do not proportionally increase efficacy and can create texture or cost issues. Below 2%, efficacy becomes questionable unless the formula includes other depigmenting synergists. Tranexamic acid works by inhibiting plasmin-mediated melanosome transfer and reducing TNF-alpha production in melanocytes; this mechanism requires adequate penetration and residence time in the epidermis, which an underarm cream formulation (typically left on for hours) supports. Stability is a critical constraint: tranexamic acid is susceptible to hydrolysis in aqueous environments, especially at neutral or high pH. Most formulations maintain pH 4.0–5.5 to preserve tranexamic acid's integrity; if your cream sits above pH 5.5 for more than a few months, potency loss accelerates. A proper preservative system (phenoxyethanol, methylchloroisothiazolinone-based preservatives, or newer preservative blends) prevents microbial growth that would otherwise lower pH and trigger hydrolysis. When specifying your formula to a cosmetic chemist, explicitly request a stabilized tranexamic acid formulation with validated stability data at pH 4.5–5.5 over 12 months at room temperature and 8 weeks at 40°C/75% RH. Kojic acid (5-hydroxy-2-hydroxymethyl-4-pyrone) similarly targets melanin production, but pure kojic acid powder is notoriously unstable—it oxidizes rapidly in water and air, turning brown and losing efficacy within weeks. This is why many manufacturers prefer kojic acid dipalmitate, a derivative in which palmitic acid is esterified to kojic acid, dramatically improving shelf life and stability. Kojic acid dipalmitate is used at 1–3% w/w; it's more stable than free kojic acid but requires a preservative system and slightly acidic pH (4.5–6.0) to prevent ester hydrolysis. Some formulations use both tranexamic acid and kojic acid dipalmitate in a single cream, targeting multiple pathways of melanin regulation; this combination is synergistic but requires careful pH and preservative balance because the two actives can interfere if not properly solubilized. Kojic acid at concentrations above 3% can cause skin irritation or sensitization in some users, especially on sensitive underarm skin; most commercially available underarm creams with kojic acid stay at or below 2% for safety and tolerability. Safety considerations are paramount for underarm formulations. The underarm is one of the most permeable regions of the skin (thin epidermis, high surface area, warm and moist microclimate), meaning any active ingredient will have higher dermal absorption than if applied to forearm or cheek. Tranexamic acid is generally recognized as safe (GRAS) in cosmetics by most regulatory bodies; no maximum concentration limit exists in the US or EU for topical tranexamic acid in cosmetics. However, systemic absorption is theoretically possible with large, repeated applications, so formulators typically stay conservative (2–5%) and include cautionary language on the label ("for external use only," "discontinue if irritation occurs"). Kojic acid, likewise, has no hard regulatory ceiling in most markets, but case reports of contact dermatitis and sensitization exist at higher concentrations; concentrations of 1–2% are considered safe for regular underarm use, while 3% and above warrant patch-test recommendations or explicit irritation warnings on the label. If your target market includes sensitive-skin consumers (a common underarm cream claim), keep tranexamic acid at 2–3% and kojic acid at 1–2% and include a hypoallergenic or dermatologist-tested claim if you have supporting data. Regulatory differences matter. In the US (FDA), both tranexamic acid and kojic acid are permissible cosmetic ingredients with no concentration limits, though the FDA scrutinizes any claim that implies a drug effect (e.g., "treats dark spots" vs. "brightens the appearance of"); if you claim therapeutic efficacy, your product crosses into drug territory and requires clinical data or an IND (Investigational New Drug) application. In the EU, tranexamic acid is not listed in Annex III (banned/restricted substances) and is permissible; kojic acid is also permitted, but the EU restricts some derivatives and impurities, so source your kojic acid or dipalmitate from a supplier who provides a Certificate of Analysis confirming purity and absence of restricted dyes or heavy metals. In China (NMPA), both ingredients are permitted in cosmetics; if you're selling into China, they will be listed on your product's packaging in Chinese and must be registered in the NMPA's cosmetics ingredient database. Australia (TGA) permits both at typical cosmetic concentrations. Japan's Ministry of Health, Labour and Welfare (MHLW) permits tranexamic acid but classifies kojic acid in a gray zone—it's not explicitly banned, but some regional prefectures have restricted it due to historical concerns about sensitization; verify local rules if entering the Japanese market. Common formulation mistakes: (1) Using free kojic acid powder instead of dipalmitate and expecting shelf life beyond 6 months—the powder oxidizes and loses efficacy. (2) Not validating pH stability after mixing tranexamic acid into an oil-in-water or water-in-oil emulsion—pH can drift over time, especially if preservative is compromised. (3) Stacking tranexamic acid + kojic acid + hydroquinone or niacinamide at high concentrations and assuming synergy without stability or safety testing—mixing multiple actives requires bench-scale validation. (4) Listing concentrations on the label—many brands do this for transparency, but if the actual batch tests at a different concentration (due to manufacturing variance or degradation), you've created a compliance risk; use vaguer language like "contains tranexamic acid and kojic acid complex" unless you have validated batch-to-batch consistency. On the AJ Cosmo Labs app, your assigned cosmetic chemist will recommend safe, effective concentrations based on your target market's regulations and your formulation's pH and preservative system; they'll also provide a stability protocol to ensure your product maintains label claims throughout shelf life.

Finding a reliable private label cosmetic manufacturer (also called a co-packer or contract manufacturer) for a tranexamic acid and kojic acid underarm cream requires evaluating three dimensions: regulatory compliance and certifications, technical capability in active-ingredient formulation, and communication and reliability. The best approach is to use a vetted platform like AJ Cosmo Labs, which connects indie founders with pre-screened cosmetic formulators, co-packers, and manufacturers across 11 CPG categories including cosmetics. The AJ Cosmo Labs app lets you filter by location, MOQ, industry specialization, certifications, and language; compare capabilities side-by-side; request quotes; and track progress in a unified inbox. This dramatically reduces the time spent on due diligence and cuts the risk of hiring a manufacturer who can't deliver on quality or timeline. When evaluating a co-packer directly (whether via AJ Cosmo Labs or independently), start with regulatory credentials. For cosmetics manufacturing in the US, confirm they are registered with the FDA's Cosmetic Facility Register and that they follow cGMP (Current Good Manufacturing Practices) standards—not legally required for cosmetics, but expected for any serious manufacturer. In the EU, verify they comply with ISO 22716 (Cosmetics—Good Manufacturing Practices) or hold a certified GMP certificate from a third-party auditor. For China, check if they are registered with the NMPA and permitted to manufacture imported cosmetics; if you're selling finished goods into China, the co-packer should understand NMPA registration requirements. Australia (TGA) and Canada (Health Canada) have analogous registration and compliance frameworks; your co-packer should be transparent about which markets they can legally serve. If a co-packer is vague about certifications or says "certifications are not necessary," walk away—it signals poor operational rigor. Second, assess their technical capability in active-ingredient formulation, specifically with tranexamic acid and kojic acid. Ask for a portfolio of underarm or brightening products they've formulated and manufactured; request stability data (specifically pH stability and microbial challenges testing) from at least two previous projects. A competent co-packer will have a dedicated cosmetic chemist on staff who understands the chemistry of tranexamic acid (hydrolysis in aqueous systems, pH sensitivity) and kojic acid dipalmitate (oxidation risk, ester stability). During an initial consultation call, ask them how they would formulate a stabilized tranexamic acid system at 3% in an underarm cream base and what preservative approach they'd recommend; their answer should mention pH buffering, specific preservative classes (phenoxyethanol, benzyl alcohol, or stabilized preservative blends), and accelerated stability protocols. If they respond with generic "we use a standard formula," that's a red flag—your actives deserve a bespoke stabilization strategy. Some co-packers specialize in actives-rich formulations; others focus on simpler, commodity cosmetics; identify which category your co-packer falls into and hire accordingly. Third, evaluate communication, transparency, and reliability. Red flags include: (1) Vague MOQ quotes (e.g., "starting at 500 units" without a timeline or price breakdown). (2) No written terms or service agreement. (3) Slow response times (more than 2 business days to initial inquiry). (4) Unwillingness to provide references from previous clients. (5) No clear project timeline or milestone structure. Green flags include: (1) A dedicated project manager assigned to your account. (2) Detailed, written quotes with itemized costs (R&D, materials, labor, packaging, QA). (3) A formalized project charter or timeline document. (4) Transparency about lead times, especially for packaging. (5) Willingness to sign an NDA or work-for-hire agreement. Use AJ Cosmo Labs to filter for manufacturers who have strong reviews and communication ratings from other indie founders; the platform aggregates feedback, so you're not flying blind. Before committing to a full manufacturing run, request a micro-batch or pilot production sample. This 500 ml to 2 kg trial run should cost $200–$800 and take 2–4 weeks. It serves three purposes: (1) You can validate that the formula feels, smells, and performs as expected. (2) The co-packer can test their filling and packaging line with your chosen container. (3) You have a baseline sample to compare against full-scale batches for quality consistency. Many indie founders skip this step to save time or cost; doing so is a common mistake and often results in discovering issues (wrong viscosity, separation, pump malfunction) after the full run has been produced and boxed. Once you've narrowed your list to 2–3 candidates, request formal quotes that include: (1) Formulation and R&D fees (or confirmation they're waived if using a house formula). (2) Raw material cost per unit. (3) Manufacturing labor per unit. (4) Packaging cost per unit (itemized by component: jar, cap, label, box). (5) QA and testing fees (microbial, stability, batch records). (6) MOQ, payment terms (e.g., 50% upfront, 50% on shipment), and timeline milestones. (7) Warranty or quality guarantees (e.g., "if microbial testing fails, we remake at our cost"). Compare quotes side-by-side; the cheapest is rarely the best—a quote that's 20% lower than others often signals corners being cut on stability testing or preservative quality. Regional considerations: If you're in North America, prioritize co-packers in the US, Canada, or Mexico; they understand FDA and Health Canada requirements and have shorter lead times. If you're in Europe, EU-based co-packers are advantageous because they're already compliant with ISO 22716 and REACH regulations. If you're bootstrapping on a tight budget, some indie founders explore co-packers in Asia (India, South Korea, China) for lower manufacturing costs, but this adds shipping time (4–8 weeks), customs complexity, and language barriers; only pursue this if you're comfortable with extended timelines and can afford the upfront investment. On the AJ Cosmo Labs platform, you can filter by geography and compare regional cost and timeline trade-offs directly. Common mistakes: (1) Hiring based solely on MOQ or price. (2) Skipping the micro-batch or requesting it after the full run is already in progress. (3) Changing the formula mid-manufacturing. (4) Not requiring written regulatory compliance confirmation. (5) Hiring a food or supplement co-packer who claims cosmetic experience but lacks the validation protocols cosmetics demand. On AJ Cosmo Labs, all listed manufacturers have been admin-reviewed before listing, so you can accelerate your selection and focus your energy on comparing capability and communication fit.

Regulatory requirements for selling private label tranexamic acid and kojic acid underarm cream vary significantly by country and depend on whether you're making a cosmetic claim (brightening, evening tone) or a drug claim (treating melasma, reducing hyperpigmentation as a medical condition). In the US, the product is classified as a cosmetic if it merely cleanses, beautifies, or improves appearance; it becomes a drug if you claim it treats, prevents, cures, or mitigates disease or abnormal conditions. In the US, cosmetics require no pre-market approval—you simply ensure ingredient safety and comply with labeling rules—but drugs require clinical data and an IND (Investigational New Drug) application or a New Drug Application (NDA), adding 12–36 months and significant cost. The vast majority of indie underarm creams position themselves as cosmetics, not drugs, by using careful language on labels and in marketing ("brightens the appearance" vs. "treats dark spots"). Before your formulation is finalized, consult a regulatory specialist or cosmetic attorney to confirm your claims stay within the cosmetic box; a misclassified claim can result in warning letters from the FDA, product seizure, or fines. In the United States (FDA), your responsibilities as a cosmetic manufacturer or brand are: (1) Register your facility with the FDA (if you own the manufacturing facility) or work with a registered co-packer. (2) Ensure all ingredients are on the FDA's "Cosmetic Ingredient Dictionary" or are recognized as safe for cosmetics. Tranexamic acid and kojic acid are both listed and permissible. (3) Maintain a batch record and ingredient list for each SKU. (4) Declare all ingredients on the product label in the order of descending concentration (INCI nomenclature), using terms from the INCI Dictionary. (5) Include a warning label if the product is intended for children under 12 or has any risk of eye contact (though an underarm cream is low-risk here). (6) List allergens such as tree nuts or sesame if they're in the formulation. (7) Include your company name and address on the label. (8) Store records for at least three years and produce them on FDA request. Your co-packer typically handles batch record generation and ensures INCI compliance; you are responsible for label copy, ingredient order, and claims. Do not require clinical testing for a cosmetic claim, but the FDA can request substantiation if a claim seems exaggerated; having stability data and in-vitro efficacy studies (e.g., melanin inhibition assays) on file is prudent. In the European Union, underarm creams containing tranexamic acid and kojic acid are regulated under the EC Cosmetics Regulation (EC 1223/2009). Before sale, you must: (1) Create a Safety Assessment File (SAF) or Product Information File (PIF) that documents the formula's safety based on ingredient toxicology, concentration, pH, preservative efficacy (microbial challenge testing per ISO 11930), and stability data. (2) Verify that every ingredient is compliant with Annex III (banned/restricted substances), Annex IV (permitted colorants), and Annex V (permitted UV filters). Tranexamic acid is not restricted; kojic acid is not restricted, but some derived dyes (e.g., Acid Red, if present as an impurity) may be. (3) Notify the CPNP (Cosmetics Products Notification Portal) with your formula, facilities, and responsible person information before placing the product on the market; no approval is required, but registration is mandatory. (4) Have a responsible person (a legal entity or individual based in the EU) who oversees compliance. (5) Comply with labeling requirements: ingredient declaration in INCI, warning statements, net weight, name and address of responsible person, shelf-life or period-after-opening (PAO) symbol (e.g., "12M" for 12 months). (6) If claiming to be hypoallergenic or dermatologist-tested, back these up with documentation. The EU does not require pre-market efficacy testing for cosmetics, but you must substantiate any claims with data; a simple stability protocol and safety assessment are sufficient to comply. In China (NMPA), the regulatory pathway has become stricter in recent years. Imported cosmetics (including private label) must be registered with the NMPA before sale. The process involves: (1) Appointing a local Chinese entity or agent to act as your importer of record. (2) Submitting the formula, safety data, and manufacturing facility registration to the NMPA. (3) Awaiting NMPA review and approval, which typically takes 4–8 weeks for standard cosmetics (no clinical testing required). (4) Complying with Chinese labeling: Chinese language ingredient declaration, warnings, usage instructions, importer/manufacturer contact info. (5) Tranexamic acid and kojic acid are both permissible in China; they do not appear on restricted lists. (6) If making brightening or whitening claims, the NMPA scrutinizes the language; claims must not imply efficacy equivalent to a drug. Working with a Chinese co-packer or an import agent who understands NMPA filing is essential because procedural delays or incomplete submissions can stall your launch by weeks. Do not ship product to China for sale before NMPA approval; if caught, product is seized. In Australia (TGA), cosmetics follow the Australian Consumer Law and TGA's Therapeutic Goods Administration rules. Tranexamic acid and kojic acid are permissible in cosmetic products. Before selling, you must: (1) Ensure the formula meets the Australian Safety Standards. (2) Declare ingredients in English using INCI nomenclature on the label, plus the product name, net quantity, directions for use, and any warnings (e.g., "Avoid eye contact"). (3) Include the name and address of the responsible person (manufacturer or local distributor). (4) If claiming therapeutic benefit (treating melasma, etc.), the product is reclassified as a Therapeutic Good and requires TGA approval, clinical data, and registration—do not make therapeutic claims unless prepared for this pathway. (5) If you're claiming brightening or toning (cosmetic claims), no pre-approval is needed, but TGA can audit your substantiation post-market. The TGA does not require pre-market registration for cosmetics, but marketing claims must be truthful and substantiated. Canada (Health Canada) follows the Natural and Non-prescription Health Products Directorate (NNHPD) for cosmetics. Tranexamic acid and kojic acid are permissible. Before sale: (1) Ensure all ingredients comply with the Canadian Cosmetics Regulations. (2) Label in both English and French, including ingredient declaration, net quantity, directions, warnings, and manufacturer/distributor contact info. (3) If claiming to treat a disease or abnormal condition, the product crosses into "Natural Health Product" or "Drug" territory and requires licensing and clinical evidence; avoid such claims. (4) No pre-market approval is required for cosmetics, but Health Canada can demand substantiation post-market. Key compliance steps across all markets: (1) Micro-batch stability testing (4–8 weeks at 40°C/75% RH, plus room temperature baseline) to confirm tranexamic acid and kojic acid remain potent and the formula is microbiologically safe. (2) Microbial challenge testing per ISO 11930 (or equivalent) to validate your preservative system prevents mold, bacteria, and yeast growth. (3) pH and viscosity stability over 12 months at room temperature. (4) INCI ingredient nomenclature compliance (e.g., "Tranexamic Acid," "Kojic Acid" or "Dipalmitoly Kojic Acid"). (5) Written claim substantiation (if you say "brightens," have data supporting that claim—efficacy studies, consumer trials, or literature). (6) Label copy reviewed by a regulatory specialist before printing. (7) Batch records with formula, material lots, manufacturing date, QA results, and expiration date. Common mistakes: (1) Launching without confirming your claims are cosmetic, not drug-level. A single phrase ("treats," "cures," "heals") can trigger FDA enforcement. (2) Skipping microbial challenge testing and then discovering your product supports mold growth mid-shelf-life. (3) Assuming a formulation legal in one market (e.g., US) is legal everywhere; regulations differ, especially in China and Australia. (4) Not translating labels and safety files into local languages where required (China, Canada, Quebec). On the AJ Cosmo Labs platform, your assigned co-packer and regulatory resources can guide you through market-specific requirements; some co-packers offer compliance consultation as a service, bundling regulatory review with manufacturing. Investing in upfront compliance avoids costly recalls, seized inventory, or rebranding later.

Validating stability and efficacy of tranexamic acid and kojic acid in your underarm cream requires three phases: bench-top formulation testing during development, accelerated stability testing per international standards, and optionally consumer or clinical validation studies. Real stability testing typically spans 8–16 weeks for accelerated conditions (40°C/75% RH) and 12 months for real-time room temperature storage; this is not optional if you're claiming efficacy or making "brightening" promises on the label. The goal is to ensure your active ingredients do not degrade, your preservative system remains effective, and the product maintains its sensory and chemical properties (appearance, odor, viscosity, pH) for the entire labeled shelf life. Without this data, you risk launching a product that separates, oxidizes, or loses potency mid-shelf, damaging your brand and creating regulatory exposure. During the formulation development phase (weeks 2–4 of your project timeline), the cosmetic chemist performs bench-scale trials using high-performance liquid chromatography (HPLC) or UV-Vis spectroscopy to measure tranexamic acid and kojic acid concentration in freshly prepared micro-batches. They will also assess the formulation's pH drift over 24–48 hours, because tranexamic acid is highly susceptible to hydrolysis in aqueous systems. If pH rises above 5.5, tranexamic acid begins to degrade; if it falls below 4.0, some surfactants or emulsifiers may destabilize. A proper bench-test includes: (1) Measuring initial pH (target: 4.5–5.5 for tranexamic acid stability). (2) Retesting pH after 24 hours at room temperature and at 40°C to detect acidification or alkalinization. (3) Visual inspection for phase separation, color change (especially critical for kojic acid, which turns brown if oxidized), or odor shift. (4) Optional HPLC or UVVIS measurement of active concentration after 24 and 48 hours to quantify any early degradation. The chemist will tweak the buffer system (usually citric acid, sodium citrate, or acetate buffers) and preservative package until pH remains stable; this iterative cycle typically takes 1–2 weeks. Skipping bench-testing and going straight to a micro-batch production run delays the project by 3–4 weeks if issues emerge at scale. Once the formula is locked, a micro-batch (2–5 kg) is produced in the co-packer's GMP facility and filled into the intended packaging (airless jar, pump bottle, tube, etc.). This pilot batch is subject to accelerated stability testing per the International Cosmetic Ingredient Dictionary and Standards or ICH (International Council for Harmonisation) Q1A/Q1B guidelines, which most cosmetic labs adopt. The accelerated protocol places filled, sealed samples in a climatic chamber at 40°C ± 2°C and 75% relative humidity ± 5% RH for 4 to 8 weeks (sometimes 12 weeks for high-risk actives). Samples are withdrawn at weeks 0 (baseline), 1, 2, 4, and 8; each timepoint is analyzed for: (1) Physical appearance (color, consistency, separation, mold/mildew growth). (2) pH (must stay within target range, e.g., ± 0.5 units from initial). (3) Viscosity (typically within ± 10% of initial for a cream). (4) Active ingredient concentration (HPLC or spectroscopy) to confirm tranexamic acid and kojic acid loss is below acceptable limits, usually defined as no more than 10% loss over 8 weeks at accelerated conditions, which extrapolates to minimal loss over 2 years of real-time storage. (5) Microbial content (aerobic plate count, yeast/mold, objectionable organisms per ISO 21149 or USP methods) to ensure preservative efficacy. (6) Water activity (optional, but relevant if you suspect moisture uptake) and viscosity (optional, but important for pump or bottle flow consistency). In parallel with accelerated testing, real-time stability samples are stored at room temperature (20–25°C, <60% RH) and subjected to the same analyses at weeks 0, 2, 4, 8, 12, and then monthly through 12 months. Real-time data is the gold standard for regulatory compliance because it reflects actual consumer storage conditions; accelerated data is predictive but cannot fully account for real-world factors (temperature fluctuations, light exposure, humidity cycling). Regulations in most markets (US FDA, EU CPNP, NMPA) accept 4–8 weeks of accelerated data as a preliminary safety indicator, but prefer or require 12 months of real-time data before a final shelf-life claim. If you're launching quickly and cannot wait 12 months, you can file for approval with accelerated data alone (declaring a conservative, shorter shelf life, e.g., 6 months), then update the shelf-life claim once 12-month data arrives; this is a common practice among indie brands and is acceptable to regulators provided you inform consumers of the initial conservative shelf life in your launch marketing. Microbial challenge testing (preservative efficacy testing) per ISO 11930 is critical for tranexamic acid and kojic acid creams because both actives and water-based emulsions are susceptible to microbial contamination; a compromised preservative system leads to mold (visible growth), bacterial overgrowth (odor and pH shift), or yeast, all of which accelerate active ingredient degradation. In ISO 11930, your product is deliberately inoculated with standardized cultures of bacteria (Staphylococcus aureus, Pseudomonas aeruginosa), fungi (Candida albicans), and mold (Aspergillus brasiliensis) at high levels (typically 10^7 CFU/ml). The microbial count is then tracked over 4 weeks of storage (often at 20–25°C and sometimes at 37°C for higher sensitivity). A passing result shows that the preservative system kills or inhibits all inoculated organisms, reducing viability by 99.9% or more within defined timeframes (usually 2–4 weeks). If your preservative system fails this test, the formulation is reformulated with a different preservative or higher concentration until ISO 11930 is passed. This is expensive (ISO 11930 testing costs $1,500–$3,000 per product) and takes 4 weeks, but it is non-negotiable for any water-based cream claiming multiple weeks of shelf life; skipping it exposes you to product recalls, consumer safety issues, and regulatory enforcement. Optional but valuable: In-vitro efficacy testing (melanin inhibition assays or tyrosinase inhibition assays) confirms that your tranexamic acid and kojic acid remain biologically active. These assays measure the ability of a diluted, extracted sample from your finished product to inhibit tyrosinase enzyme or reduce melanin production in cell culture; the results are compared to a baseline (freshly formulated product) and to a positive control (e.g., pure tranexamic acid at the same concentration in a simple aqueous buffer). If real-time samples at 6 or 12 months show significant loss of efficacy (e.g., >15% reduction in tyrosinase inhibition), the active ingredient or emulsion chemistry has degraded faster than expected. This early warning lets you shorten your declared shelf life or reformulate before consumer complaints arrive. In-vitro testing costs $1,500–$2,500 per timepoint; many indie brands conduct this at baseline and 6 months to verify the trajectory. On the AJ Cosmo Labs platform, your co-packer can coordinate in-vitro testing through affiliated third-party labs, ensuring results are independent and defensible for marketing claims. Cold-chain and light exposure studies are optional but increasingly important for tranexamic acid and kojic acid, which are sensitive to oxidation and temperature. Some brands conduct supplementary testing at cooler conditions (e.g., 2–8°C) or in light-exposed storage (exposed to indirect sunlight or standard fluorescent light for 4–8 weeks) to verify no accelerated degradation. If your product is marketed as premium or cosmeceutical, these data reinforce quality perception and can justify a higher shelf-life claim or label recommendations ("store in a cool, dark place"). Documentation and regulatory reporting: All stability data (HPLC chromatograms, pH logs, viscosity records, microbial results) must be compiled into a Stability Summary or included in your Product Information File (PIF) for EU CPNP notification or Safety Assessment File (SAF) for cosmetics marketed in multiple regions. In the US, the FDA does not require pre-submission of stability data, but you must retain it for three years on-site and produce it if audited. In China (NMPA), stability data is requested as part of the import cosmetics registration. Presenting your stability data clearly (with tabulated results and graphed trends) demonstrates professionalism and can accelerate regulatory review. Common stability challenges and how to address them: (1) Tranexamic acid pH-drift: Add a buffering system (sodium citrate + citric acid) tuned to pH 4.5, and use a preservative that stabilizes pH (phenoxyethanol helps). (2) Kojic acid browning: Substitute kojic acid dipalmitate (more stable) or add antioxidants (alpha-tocopherol, sodium ascorbate, or chelating agents like EDTA) and package in opaque or amber-colored bottles to block light. (3) Separation or texture change: Optimize the emulsifier system and ensure water phase is below 50% by weight; add thickeners (xanthan gum, carbomers) to stabilize texture if needed. (4) Microbial challenge failure: Increase preservative concentration or switch to a broad-spectrum preservative blend; some formulators add paraben-free blends (e.g., Glydant Plus, Euxyl PE 9010) that perform better in actives-rich formulations. (5) Odor or discoloration: Reduce fragrance concentration (perfume oils can oxidize and turn formulations yellow), avoid raw materials with high microbial loads (inspect supplier CoA for aerobic plate count <10^3 CFU/g), and store stability samples away from direct light. Timeline reality: A full stability package (8-week accelerated + 12-week real-time preliminary + ISO 11930 + optional in-vitro at weeks 0 and 6) takes 12–16 weeks from micro-batch production. If you're launching within 3–4 months, you can submit 8-week accelerated data + 4-week real-time + ISO 11930 to regulators and declare a conservative shelf life (6–8 months), then update your label and marketing once 12-month data confirms longer shelf life is safe. Many indie brands do this; it's a standard practice and does not trigger regulatory concern provided you're transparent. On the AJ Cosmo Labs app, your co-packer and QA partner can schedule stability timepoints to align with your launch date and provide preliminary reports early, keeping you on track.